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Abstract
Background: Rapidly regenerating tissues need sufficient polyamine synthesis. Since the hair follicle (HF) is a highly
proliferative mini-organ, polyamines may also be important for normal hair growth. However, the role of polyamines in
human HF biology and their effect on HF epithelial stem cells in situ remains largely unknown.
Methods and Findings: We have studied the effects of the prototypic polyamine, spermidine (0.1–1 mM), on human scalp
HFs and human HF epithelial stem cells in serum-free organ culture. Under these conditions, spermidine promoted hair
shaft elongation and prolonged hair growth (anagen). Spermidine also upregulated expression of the epithelial stem cell-
associated keratins K15 and K19, and dose-dependently modulated K15 promoter activity in situ and the colony forming
efficiency, proliferation and K15 expression of isolated human K15-GFP+ cells in vitro. Inhibiting the rate-limiting enzyme of
polyamine synthesis, ornithine decarboyxlase (ODC), downregulated intrafollicular K15 expression. In primary human
epidermal keratinocytes, spermidine slightly promoted entry into the S/G2-M phases of the cell cycle. By microarray analysis
of human HF mRNA extracts, spermidine upregulated several key target genes implicated e.g. in the control of cell
adherence and migration (POP3), or endoplasmic reticulum and mitochondrial functions (SYVN1, NACA and SLC25A3). Excess
spermidine may restrict further intrafollicular polyamine synthesis by inhibiting ODC gene and protein expression in the
HF’s companion layer in situ.
Conclusions: These physiologically and clinically relevant data provide the first direct evidence that spermidine is a potent
stimulator of human hair growth and a previously unknown modulator of human epithelial stem cell biology.
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Introduction
Polyamines (spermidine, putrescine and spermine) are multi-
functional polycationic aliphatic amines, which serve crucial roles
in cell survival. Besides serving as nutrients and metabolic
regulators [1,2], polyamines have been implicated as mediators
of key cell functions, such as proliferation, migration and
differentiation [3–7]. Polyamines also stabilize DNA/RNA and
modulate DNA replication/transcription [1,2,8–10], and stabilize
membrane and cytoskeletal proteins [11,12]. Recently a key
polyamine, spermidine, has even been hailed as a new longevity
agent due to its impact on chromatin-mediated regulation of gene
expression [13]. While polyamines are indispensable for cell
proliferation, and are needed for the growth of rapidly
regenerating tissues and tumors [14,15], the full spectrum of
functions of spermidine in normal human tissue physiology remains
poorly understood [16].
The hair follicle (HF) is one of the most highly proliferative
organs in mammalian biology [17,18]. Therefore, polyamines
have long been suspected to be important for hair growth [19]. For
example, inhibiting polyamine synthesis significantly modulates
murine hair growth [20], and polyamines have an essential role in
determining sheep HF growth and diameter [21]. In addition, a
recent study has shown that a topical administration of a-
methylspermidine, a stable analogue of spermidine, induced hair
growth in telogen phase mice [22]. Surprisingly, however, studies
utilizing several transgenic mice lines with altered polyamine
metabolism [6,19,20,23–28] showed that the most prominent
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phenotype of these mice was hair loss due to disturbed
proliferation of follicular keratinocytes.
In human skin, topical application of eflornithine (difluoro-
methylornithine, DFMO), an inhibitor of ornithine decarboxylase
(ODC), the rate limiting enzyme in the polyamine biosynthesis
pathway [29], can reduce undesired, excessive hair growth
[30,31]. We have previously shown that addition of DFMO to
organ-cultured human scalp HFs shortens the growth phase of the
hair cycle (anagen) and inhibits hair shaft production, accompa-
nied by a decrease in matrix keratinocyte proliferation [32].
However, whether and how spermidine itself affects human hair
growth directly is unknown.
Therefore, we have exploited the HF as an excellent model
system for exploring physiological polyamine functions in human
skin [29]. Specifically, we have studied in normal, microdissected
human scalp HFs under serum-free organ culture conditions [33–
35] whether spermidine impacts on basic hair biology parameters.
We opted for testing the spermidine doses that have been
previously shown to modulate wool follicles growth in organ
culture [21], and that correspond to the physiological spermidine
levels in human plasma [36]. Using keratin 15 (K15) expression
and K15 promoter-driven green fluorescent protein (GFP)
expression as a system for assessing human epithelial HF stem
cell functions in situ and in vitro [35,37,38], we also explored
whether spermidine alters human HF epithelial stem cell
clonogenicity, whose modulation by polyamines is as yet unknown
[17,18,38,39].
Results
Spermidine stimulates hair-shaft elongation and
prolongs anagen
Administration of spermidine for 6 days slightly, but signifi-
cantly, increased hair shaft growth of microdissected, organ-
cultured normal human scalp HFs (Figure 1A). This effect was
maximal and significant at 0.5 mM, and led to more than a 20%
increase in hair shaft production after 6 days in culture (Figure 1B).
However, whether spermidine can also prolong the duration of
anagen is clinically much more important than the effect on hair
elongation since this directly impacts on the amount of hair that is
shed (e.g., a reduced percentage of HFs in anagen, clinically, will
inevitably result in a higher percentage of catagen and
subsequently telogen HFs, thus leading to telogen effluvium –
and vice versa) [17,18,40]. To assess this, quantitative hair cycle
histomorphometry was performed [41,42]. Indeed, after 6 days of
organ culture, all doses of spermidine investigated led to an
increase in the percentage of HFs in anagen, and decreased that of
catagen HFs (Figure 1C). In the presence of spermidine, only 47–
52% of the HFs spontaneously entered catagen, while 67% of the
control HFs had already done so.
Spermidine downregulates ODC expression in the HF
ODC, the rate-limiting enzyme of polyamine synthesis,
reportedly is expressed in highly proliferative hair matrix
keratinocytes [29,43]. We have also demonstrated that ODC is
present in the matrix keratinocytes of human anagen VI HFs
(Fig. 2A). However, surprisingly, high immunoreactivity was also
evident in the companion layer of the HF (Fig. 2A).
Since polyamines negatively regulate ODC activity, both on
transcriptional and post-transcriptional level [29], we checked
whether any such effect is also apparent in spermidine-treated
HFs. We found that spermidine treatment for 6 days downreg-
ulated ODC protein expression in situ (Figure 2B), and showed a
tendency towards decreased ODC mRNA transcription after 24 h
treatment (Figure 2C), though the latter was not significant.
However, in isolated, cultured human HF-derived outer root
sheath (ORS) keratinocytes, 0.5 mM spermidine treatment for
48 h significantly downregulated ODC mRNA expression
(Figure 2D). Together, these data suggest that excess spermidine
induces intracellular counter-regulatory events in human HF
epithelium in situ through which further intrafollicular polyamine
synthesis is restricted by inhibiting ODC gene and protein
expression.
Spermidine stimulates human hair matrix and epidermal
keratinocyte proliferation
The fact that spermidine prolonged anagen suggested effects on
highly proliferative hair matrix keratinocytes [17,18]. In situ,
spermidine slightly, but not significantly stimulated hair matrix
Figure 1. Spermidine treatment increases hair shaft elongation and prolongs anagen. A. Spermidine treatment for 6d increased hair shaft
elongation of microdissected organ cultured HFs, maximal and significant in the 0.5 mM dose. In this clinically highly relevant in vitro-assay,
amputated HFs in the growth phase of the hair cycle (anagen) continue for several days to produce a pigmented hair shaft at almost the normal
speed of normal anagen HFs in vivo, and display cyclic growth activity in vitro by spontaneously entering into the regression phase of the hair cycle
(catagen). B. Total increase in hair shaft elongation relative to control after 6d in culture (cumulative results of two different experiments). C.
Spermidine treatment prolonged anagen in all three doses after 6d in culture. *P,0.05. Columns represent means6SEM; n = 30–36 HFs/group;
cumulative results of two different experiments.
doi:10.1371/journal.pone.0022564.g001
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keratinocyte proliferation, as assessed by quantitative Ki67-
immunohistomorphometry (Figure 3A), and did not significantly
alter hair matrix keratinocyte apoptosis (Figure 3A). However,
fluorimetric proliferation assays revealed that spermidine dose-
dependently stimulated the proliferation of cultured primary
human epidermal keratinocytes (Figure 2B). FACS analysis
revealed that spermidine promoted the accumulation of cells in
the S/G2-M phases of the cell cycle (data not shown). Thus, the
promotion of S/G2-M entry by human HF keratinocytes may be
one potential mechanism by which spermidine may exert its
anagen-prolonging effects.
Spermidine differentially modulates the gene expression
profile of human HFs
In order to identify potential (direct or indirect) target genes of
spermidine action in human HFs, a genome-wide microarray
analysis was performed on two independent sets of organ-cultured
human scalp HFs, derived from two healthy female volunteers (aged
47 and 67 yrs), which had been treated with 0.5 mM spermidine or
vehicle for 24 h and 48 h, respectively. In order to check which
genes are being constitutively activated following spermidine
administration, we made a comparison between these two time-
points. Adopting rigid selection criteria, i.e. selecting only those
genes whose intrafollicular transcription was modified .2-fold
(p , 0.05) into the same direction in both individuals, only five
genes were identified as significantly and equidirectionally up-
regulated by the tested spermidine dose (Table 1). Of these
spermidine-regulated genes, SYVN1 and NACA are known to be
important for normal cell homeostasis and function, including
endoplasmic reticulum-associated protein degradation [44] and
folding and targeting of nascent proteins [45]. SLC25A3 encodes a
mitochondrial phosphate carrier, essential for the aerobic synthesis
of adenosine triphosphate [46], and POP3 is important for cell
adherence and migration [47] (see Discussion for details).
Spermidine up-regulates expression of the epithelial
stem cell-associated keratins K15 and K19, and
modulates K15 promoter activity in situ
Anagen maintenance requires constant production of HF
keratinocytes from resident epithelial stem cells (eSCs) and their
progeny, which are thought to migrate towards the hair matrix
[18,48]. Since polyamines have been shown to be required for the
migration [3,4] and differentiation of various progenitor cell
populations [5–7,49] as well as for cell cycle progression [50,51],
we therefore addressed whether spermidine also affects human HF
eSCs. These cells are located primarily in the bulge and are
characterized by expression of K15; however, K15+ progenitors
are also found further down the ORS [17,18,38,39].
Figure 2. Spermidine treatment down-regulates ODC expression in the HF. A. Immunoreactivity of ODC in the proximal HF demonstrates
moderate ODC expression in the matrix keratinocytes, and strong expression in the proximal companion layer. B. Spermidine treatment for 6d
decreased ODC immunoreactivity in the lower doses (0.1 and 0.5 mM). Columns represent means6SEM; n = 9–13 HFs/group C. By Q-PCR, spermidine
treatment for 24 h slightly decreased the ODC transcript steady-state levels in human anagen HF mRNA extracts, compared to PPIA, although this did
not reach significances. D. However, spermidine significantly down regulated ODC transcription in cultured human ORS keratinocytes after 48 h.
*P,0.05. Columns represent means6SEM. Results represent triplicate determinations of samples. Total RNA was pooled from 20 HFs. DP, dermal
papilla; MK, matrix keratinocytes; ORS, outer root sheath.
doi:10.1371/journal.pone.0022564.g002
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Figure 3. Spermidine stimulated proliferation of primary human keratinocytes and tended to stimulate hair matrix keratinocytes.
A. By quantitative Ki67/TUNEL immunohistomorphometry, spermidine tended to slightly stimulate hair matrix keratinocyte proliferation in situ;
however, this did not reach statistical significance. No effect was seen on hair matrix keratinocyte apoptosis in situ. Columns represent means6SEM;
n = 30–36 HFs/group; cumulative results of two different experiments. B. Spermidine significantly stimulated proliferation of primary human
keratinocytes after 48 h, as assessed by fluorimetric proliferation assay. The values shown are means6SEM of triplicate experiments. Scale bars,
50 mm. Columns represent means6SEM; ***P,0.001. DP, dermal papilla; MK, matrix keratinocytes.
doi:10.1371/journal.pone.0022564.g003
Table 1. Selected genes up-regulated in HFs by spermidine (0.5 mM).
Gene name Sequence description Sample 1 Sample 2
Fold change P-value Fold change P-value
SYVN1 Synovial apoptosis inhibitor 1, synoviolin:
Ubiquitin ligase, plays a role in endoplasmic
reticulum-associated protein degradation [44].
2.81 0.012 3.74 0.002
KRT77 Keratin 77: Intermediate filament expressed in
the luminal cells of eccrine sweat glands [69]
2.58 0.006 3.24 0.005
NACA Nascent-polypeptide-associated complex alpha
polypeptide: Part of the protein translation chaperone
complex, which has an important role in cotranslational
processes, in addition to transcriptional regulation-related
processes and cell differentiation [45]
2.1 0.033 2.73 0.007
POPDC3 Popeye domain containing 3: Takes part in cell adherence
and migration, and essential for normal heart function [47,70]
2.29 0.018 2.09 0.029
SLC25A3 Solute carrier family 25 (mitochondrial carrier;
phosphate carrier), member 3: Mitochondrial
phosphate carrier, essential for the aerobic synthesis
of adenosine triphosphate [67]
3.74 0.004 2.05 0.026
doi:10.1371/journal.pone.0022564.t001
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Even though our microarray analysis had not identified any HF-
associated keratins as spermidine-regulated genes (possibly for
methodological or sub-threshold reasons), quantitative immuno-
histomorphometry of K15 expression in situ clearly showed that
spermidine significantly increased K15 immunoreactivity in the
basal layer of the proximal ORS after 6 days (Figure 4A).
To confirm this effect in isolated human HF keratinocytes,
which are not influenced by the HF mesenchyme, HF melano-
cytes, and intrafollicular hematopoietic cells, we measured the
steady-state levels of K15 mRNA in cultured human ORS
keratinocytes that had been treated for 48 h with 0.5 mM
spermidine. Indeed, K15 mRNA was upregulated after 48 h of
treatment (Figure 4B). Conversely, ODC inhibition by DMFO
significantly downregulated K15 expression after 6 days
(Figure 4C). This suggests that K15 protein expression in situ is
profoundly regulated by spermidine.
In the lower two doses tested, spermidine also significantly
increased keratin 19 (K19) protein expression after 6 days, an
independent human HF epithelial progenitor cell marker [35,52]
(Figure 4D). Additionally, 0.5 mM spermidine administration led
to increased K19 mRNA expression in organ-cultured HFs after
24 h (Figure 4E). Treatment of cultured ORS keratinocytes with
0.5 mM spermidine tended to upregulate K19 mRNA after 48 h,
but this was not statistically significant (Figure 4F).
To further explore the effect of spermidine on human HF eSCs
in the bulge [39,48], we employed a novel human K15 promoter-
driven GFP reporter assay, which demarcates K15+ human HF
epithelial progenitor cells in situ [37,38]. This revealed that
spermidine also significantly and dose-dependently modulated
human K15 promoter activity in the bulge region in situ: As
measured by the intensity of GFP fluorescence, at 0.5 mM
spermidine up-regulated the transfected K15 promoter activity in
situ, while it down-regulated it at 0.1 mM or 1 mM (Figure 5A).
Spermidine dose-dependently modulates colony forming
efficiency and K15 expression of isolated K15-GFP+ cells
in vitro
To further investigate how spermidine impacts on human HF
epithelial progenitor cells in the absence of HF mesenchyme, HF
melanocytes and intrafollicular hematopoietic cells, we isolated
and cultured human HF K15-GFP+ progenitor cells [37,38].
These experiments showed that only the 0.5 mM spermidine dose
significantly up-regulated the colony forming efficiency of K15-
GFP+ progenitor cells (Figure 5B). This spermidine dose also
increased their K15 mRNA expression on days 3 and 6 (Figure 5C),
and slightly enhanced their K15 protein expression on days 1 and
3 (Figure 5D). Furthermore, 0.5 mM spermidine also stimulated
proliferation on days 3 and 6 of these isolated human HF
progenitor cells in vitro (Figure 5D). In contrast, 1 mM spermidine
significantly inhibited K15 mRNA expression and the proliferation
activity of K15-GFP+ cells in vitro (Figures 5C, D).
These in vitro results are comparable with the in situ observations,
which also showed maximal spermidine growth-modulatory effects
on the intact HF mini-organ at the same dose. Taken together, this
suggests that the spermidine-induced growth-promotion of human
HFs at 0.5 mM (Figures 1A, B) may be mediated, at least in part,
by an effect on epithelial HF progenitor cells, which are also
stimulated by the same dose.
Discussion
While it has long been postulated that polyamines may stimulate
hair growth [22,29,53], the current study is the first to provide
direct evidence that this is actually the case in human HFs.
Specifically, we demonstrate that spermidine stimulates hair shaft
elongation, accompanied by prolongation of anagen, and thus
directly promotes human HF growth. This is in line with recent in
vivo evidence that topically applied alpha-methylspermidine
induces anagen in mouse telogen HFs [22].
The anagen prolongation/catagen inhibition by spermidine
demonstrated here is clinically important: If our human HF
organ culture data are transferrable to the in vivo situation,
spermidine administration may help to counteract multiple forms
of hair loss associated with excessive hair shedding. Namely,
topical or nutraceutical spermidine application may reduce
telogen effluvium in patients that suffer from hair loss due to
premature anagen termination (e.g. by androgens, perifollicular
inflammation, iron or estrogen deficiency, or effluvium-inducing
drugs) [17,54].
ODC is expressed in the anagen hair matrix [29,55], and
reducing intrafollicular spermidine synthesis by the inhibition of
ODC activity reduces human hair shaft growth and shortens
anagen duration [32]. Together with the anagen-prolonging and
hair growth-promoting effects of spermidine demonstrated here,
this suggests that intrafollicular synthesis of spermidine is
important for keeping a HF in its growth stage. However, over-
expression of ODC in mice results in the formation of dermal
cysts, leading to the opposite effect ( = hair loss) [20,25]. This is
postulated to result from the excessive accumulation of putrescine,
which causes disturbed keratinocyte differentiation and increased
proliferation. In fact, we show here that spermidine application
downregulates intrafollicular ODC expression on the gene and
protein levels (Fig. 2B-D), and may thus protect the human scalp
HF against excessive synthesis of putrescine so as to avoid
deleterious polyamine effects on human hair growth.
To our surprise, although also evident in the proliferating
keratinocytes of the hair bulb, the strongest expression of ODC
was evident in the companion layer of the HF (Fig. 2A). This
expression pattern coincides with the intriguing pattern of
expression of K6/K16, the keratins known to be expressed in
highly proliferating cells [56]. Thus, our findings add to the
mystery which still surrounds this layer in the HF, and which
awaits further investigation.
Despite the known general proliferation-stimulatory properties
of polyamines [57,58], which were confirmed here in cultured
human epidermal keratinocytes (Fig. 3B), and the demonstrated
inhibitory effects of DFMO on human hair matrix keratinocytes
[32], spermidine exerted only minor effects on hair matrix
proliferation in situ. Therefore, much of the stimulatory effect of
spermidine on hair shaft production appears to arise from a
prolongation of anagen (Fig. 1C). This supports the concept that
polyamines are potent regulators of HF cycling, not only in mice
[19,22,26], but also in man. It also provides the first evidence that
one defined polyamine, spermidine, alters HF cycling by direct
effects on the HF which are independent of extrafollicular changes
induced in the concentration of various polyamines and/or in the
activity of their multiple different target genes.
The recent provocative report that spermidine may promote
longevity [13,59] may be relevant in the current context, if one
considers that, with the notable exception of its pigmentary unit,
the HF is one of the most strikingly aging-resistant organs of the
human body [60]. Furthermore, the duration and prolongation of
anagen is a very faithful indicator of HF vitality [32,61].
Therefore, one wonders whether spermidine impacts positively
on a HF’s individual lifespan. Since the latter vitally depends on its
epithelial stem cell compartment [48,62], this raises the question
whether the normal function of HF epithelial stem cells depends
on proper intrafollicular spermidine synthesis and/or availability.
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Though our pilot study was not designed to provide definitive
proof for the validity of this hypothesis, our current data suggest
that human HF epithelial stem cells are profoundly modulated by
spermidine: Spermidine not only upregulates K15 and K19
protein expression in situ (Fig. 4A,D), but intrafollicular
spermidine synthesis is also needed for normal K15 expression
(Figure 4C). Moreover, one tested spermidine dose (0.5 mM)
stimulated K15 promoter activity and colony forming efficiency
and long-term proliferation of isolated, primary human HF
epithelial progenitors (Fig. 5A,B,D). Our observation that the
highest tested dose of spermidine (1 mM) inhibited colony forming
efficiency, K15 promoter activity, and proliferation at day 6,
might well result from the metabolism of excess spermidine to
toxic compounds that enhance oxidative damage, such as
hydrogen peroxide [29].
Although strong upregulation of K15 was evident in all of our
experiments at the 0.5 mM dose, K15 protein expression of K15-
GFP+ cells in vitro was surprisingly downregulated on day 6
(Fig. 5D). This was in contrast to the upregulation of the
corresponding mRNA expression that was observed at the same
dose (Fig. 5C). It is possible that the rapid proliferation of the K15-
GFP+ cells observed after 6 days of 0.5 mM spermidine
administration (as assessed by Ki-67 immunoreactivity, Fig. 5D)
did not allow enough time for the K15 protein to assemble in the
cells, and to reach the level of detection. It has also been shown
before that polyamines have an effect on the post-translational
regulation of proteins, affecting protein degradation by direct or
indirect effect on proteases [63]. Therefore, changes in protein
expression may not always correlate with the changes observed at
the mRNA level.
Our study presents the first evidence that spermidine is a novel
determinant in human eSCs biology, most notably of K15 and
K19 expression by primary human epithelial progenitor cells in situ
and in vitro. These findings are in line with the prior demonstration
that ODC is expressed in the bulge region of the HF [55,64],
where it colocalizes with that of K15 and K19 expression [52].
While polyamines are known to affect the keratin composition of
wool follicles [21], it was previously unknown that polyamines
actually regulates the expression of human eSC-associated
keratins.
Moreover, we provide the first available evidence that inhibiting
the key enzyme of polyamine synthesis (ODC) down-regulates
K15 expression. Thus K15 expression in situ is profoundly
regulated by spermidine, and both polyamines and ODC activity
impact on the expression of this HF epithelial progenitor cell
marker keratin. Our finding that ODC expression on the gene and
protein level (and thus likely ODC activity) underlies a negative,
dose-dependent feedback regulation by spermidine (Fig. 2B)
underscores the apparent importance of keeping intrafollicular
polyamine synthesis in check. That the highest dose of spermidine
tested did not reduce ODC expression (Figure 1B) may suggest
that adequate ODC activity remains needed as a part of the
biological stress response to excessive spermidine levels.
We had hoped to obtain specific leads from our microarray
analysis on how spermidine may exert its anagen-prolonging, stem
cell-modulatory, and K15/K19-regulatory effects. While these
results identified five novel intrafollicular candidate target genes for
spermidine-mediated signaling (Table 1) that have not yet been
investigated in the spermidine literature, these genes do not
sufficiently explain the underlying mechanisms of action. Howev-
er, the fact that the identified candidate genes are important for
vital cell organelles and cell homeostasis fits well to the general
concept that spermidine supports HF and eSC vitality.
For example, synoviolin (coded by SYVN1) is a ubiquitin ligase,
which plays an important role in endoplasmic reticulum-associated
protein degradation [44], the NACA gene encodes the nascent-
polypeptide-associated complex alpha polypeptide, a part of the
protein translation chaperone complex [45], and SLC25A3 is a
mitochondrial phosphate carrier, which is essential for the aerobic
synthesis of adenosine triphosphate [65]. Particularly interesting
potential spermidine target gene is POP3, which belongs to the
highly conserved popeye domain-containing family, and has been
implicated in cell adherence and migration [47]. Although these
microarray results could not be further validated since all available
HF samples and sections had been consumed for the analyses
reported here, our preliminary data provide new leads to
previously unsuspected (direct or indirect) spermidine target genes
in human tissue physiology.
An intriguing chance observation of our study was the finding
that spermidine clearly up-regulated transcription of K77 in the
HFs of two female patients (Table 1). Since this keratin has
previously been claimed to be exclusively expressed in eccrine
glands, we are now following this lead up on the gene and protein
level in order to obtain deeper insights into the unexpected and
enigmatic functions that K77 may have in human HF biology, and
why expression of this gene is so spermidine-sensitive.
In summary, our study provides the first evidence that
spermidine directly impacts on the growth, cycling, keratin
expression and epithelial progenitor functions of human HFs.
Due to its anagen-prolonging effects, spermidine deserves rigorous
clinical testing as a candidate anti-hair loss agent. It could become
an adjuvant therapy for hair loss disorders associated with
premature catagen induction, leading to telogen effluvium, and/
or reduced hair shaft production. Moreover, we show that the
complex regulatory role of polyamines in human epithelial biology
in situ extends far beyond the mere stimulation of proliferation.
Our study also documents that, to further dissect the full range of
polyamine functions in normal human tissue physiology, human
HF organ culture offers a highly instructive, clinically relevant
research tool (34).
Materials and Methods
HF organ culture
Anagen VI HFs were microdissected from normal temporo-
frontal human scalp skin obtained after written informed patient
Figure 4. Spermidine up-regulates expression of the epithelial stem cell-associated keratins K15 and K19. A. Spermidine treatment for
6d increased K15-like immunoreactivity in the 0.5 mM and 1 mM doses, as assessed by quantitative immunoreactivity. n = 10–15 HFs/group;
cumulative results of two different experiments. B. Spermidine significantly upregulated K15 mRNA expression in cultured ORS keratinocytes after
48 h of treatment. Results represent triplicate determinations of samples. Total RNA was pooled from 20 HFs. C. DFMO (400 mg/l) significantly
decreased K15-like immunoreactivity after 6d. n = 6–8 HFs/group. D. Spermidine treatment for 6d increased K19-like immunoreactivity in the 0.1 mM
and 0.5 mM doses, as assessed by quantitative immunoreactivity. n = 30–36 HFs/group; cumulative results of two different experiments. E. By Q-PCR,
spermidine treatment for 48 h significantly increased the K19 transcript steady-state levels in human anagen HF mRNA extracts. F. Treatment of ORS
keratinocytes for 48 h showed a tendency of K19 mRNA upregulation, but these results were not statistically significant. Results represent triplicate
determinations of samples. Total RNA was pooled from 20 HFs. Scale bars, 50 mm. Columns represent means6SEM; *P,0.05; **P,0.01. ORS, outer
root sheath.
doi:10.1371/journal.pone.0022564.g004
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Figure 5. Spermidine modulates colony forming efficiency and K15 expression of isolated K15-GFP+ cells in vitro. A. Spermidine
regulates expression of K15 promoter-driven GFP expression in hair follicles in situ in a dose-dependent manner; scale bars, 100 mm. B. Colony
formation assay of isolated and cultured K15-GFP+ under different spermidine concentrations revealed that 0.5 mM spermidine significantly
upregulated colony forming efficiency, whereas 0.1 and 1 mM reduced it. C. Quantitative RT-PCR of K15 in isolated and cultured K15-GFP+ cells under
the presence of spermidine. K15 expression is presented in comparison to the housekeeping gene rS26. D. Evaluation of proliferative and apoptotic
events in isolated and cultured K15-GFP+ cells under the influence of spermidine for 6 days. At three time points (d1, d3, and d6) cells were labeled
with K15, Ki-67 and DAPI. K15- and Ki-67-positive cells were counted and expressed as percentage of all DAPI-positive cells (nuclei). Error bars
represent means6SEM; data were analysed by unpaired Student’s t-test (vehicle group vs. test group; A, C) and two-way ANOVA test (within
corresponding groups; B, D);*P,0.05; **P,0.01;***P,0.001.
doi:10.1371/journal.pone.0022564.g005
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consent from ten healthy adult females undergoing routine facelift
surgery, adhering to the Helsinki guidelines and following
approval by the Institutional Research Ethics Committee of the
University of Lu¨beck. In this clinically highly relevant in vitro-assay,
amputated HFs in the growth phase of the hair cycle (anagen)
continue for several days to produce a pigmented hair shaft at
almost the normal speed of normal anagen HFs in vivo, and display
cyclic growth activity in vitro by spontaneously entering into the
regression phase of the hair cycle (catagen). For immunohisto-
chemical studies, isolated HFs from four individuals were used for
routine 6-day HF organ culture as previously described [17,18,32-
35]. Spermidine (0.1, 0.5 or 1 mM), DFMO (400 mg/l) or vehicle
(distilled water) were administered once for each change of culture
medium (every 48 h). After 6 days, all test and control HFs were
embedded, snap-frozen, and processed for longitudinal cryosec-
tioning. The frozen sections were stored at 280uC until used. HFs
from one individual were used for a 24 h organ culture, and
utilized for a genome-wide microarray essay and quantitative PCR
(qPCR). HFs from four additional individuals were subjected to
48 h organ cultures. HFs from two individuals were used for K15
promoter-driven green fluorescent protein (GFP) expression
construct transfection (see below). HFs from an additional one
female patient were used for a genome-wide microarray essay.
HFs from one individual were used for isolating and culturing of
K15-GFP positive cells.
Measurement of hair-growth parameters
Hair-shaft length measurements of vehicle and spermidine-
treated HFs in organ culture was performed on d 0, 1, 4 and 6,
using a Zeiss inverted binocular microscope with an eyepiece
containing a graticule (Carl Zeiss, Oberkochen, Germany). It
should be noted that hair-shaft elongation in serum-free human
HF organ culture occurs at almost the same rate of normal hair
growth in vivo [34]. HF cycle staging (i.e., anagen VI vs. catagen)
was assessed histologically after 6 days of organ culture using
hematoxylin–eosin (Sigma-Aldrich, Taufkirchen, Germany)
stained frozen sections. The hair cycle stage was classified
according to accepted morphological criteria [32].
Analysis of HF matrix keratinocyte proliferation and
apoptosis
To evaluate apoptotic cells in colocalization with a prolifera-
tion marker Ki-67 of cells in the HF, Ki-67/TUNEL (terminal
dUTP nick endlabeling) double-immunofluorescence was used as
described previously [33]. Briefly, 6- mm cryosections were fixed
in paraformaldehyde and ethanol-acetic acid (2:1) and labeled
with a digoxigenin-deoxyUTP (ApopTag Fluorescein In Situ
Apoptosis Detection Kit; Chemicon, Purchase, NY, USA) in the
presence of terminal deoxynucleotidyl transferase (TdT), followed
by incubation with a mouse anti-Ki-67 antiserum (Dako,
Glostrup, Denmark). TUNEL-positive cells were visualized by
an anti-digoxigenin FITC-conjugated antibody (ApopTag kit),
whereas Ki-67 was detected by a rhodaminelabeled goat anti-
mouse secondary antibody (Jackson Immuno- Research, West
Grove, PA, USA). Counterstaining was performed with 49,6-
diamidino-2-phenylindole (DAPI) (Roche Molecular Biochemi-
cals GmbH, Mannheim, Germany). Negative controls were run
by omitting TdT or the primary Ki-67 antibody and by observing
negative immunoreactivity for these parameters in the expected
human scalp skin compartments. For the quantitative evaluation
and comparison of the double-staining, DAPI-, Ki-67-, or
TUNEL-positive cells were counted in clearly defined reference
regions. The number of DAPI-positive cells served as ‘‘total
number of cells,’’ and the percentage of Ki-67-positive and/or
TUNEL-positive cells was calculated on this basis to enable
comparison between vehicle and test groups.
ORS keratinocyte culture
Plucked HFs were digested using trypsin to obtain human ORS
keratinocytes, as described previously [66]. ORS cultures were
kept on a feeder layer of mitomycin-treated human dermal
fibroblasts [67] in a 1:3 mixture of Ham’s F12 (Biochrom, Berlin,
Germany) and Dulbecco’s modified Eagle’s medium (Invitrogen-
Life Technologies, Inc., Grand Island, NY, USA) supplemented
with 0.1 nM cholera toxin, 5 mg/ml insulin, 0.4 mg/ml hydrocor-
tisone, 2.43 mg/ml adenine, 2 nM triiodothyronine, 10 ng/ml
epidermal growth factor, 1 mM ascorbyl-2-phosphate, and
antibiotics (all from Sigma-Aldrich Corp.).
Quantitative immunohistochemistry of K15, K19 and
ODC
Expression of K15 and K19 was studied using our previously
described tyramide signal amplification protocol and basic
immunohistology protocols [35]. For ODC immunohistochemistry,
rabbit anti-human ODC antibody (Abnova, 1:500) was used. As
negative controls for all stainings, the respective primary antibodies
were omitted. In addition, morphological criteria and reproduction
of the previously published HF expression pattern of K15 and K19
was used as internal positive or negative controls [35], and for
ODC, expression pattern in the epidermis was used as a positive
control. Densitometric measurements of staining intensities in
previously defined reference areas (quantitative immunohistomor-
phometry) we performed using the ImageJ software (National
Institute of Health, Bethesda, USA), as previously described [33].
Statistical analysis was assessed by unpaired t test, using Graph Pad
Prism 5.01 (Graph Pad Software, Inc., San Diego, CA, USA).
Microarray
Gene expression analysis of HFs from two female subjects
(50 HFs from each subject) using an Agilent Human Whole
Genome Oligo Microarray (44K) was performed by Abiol Ltd.
(Debrecen, Hungary) as a commercial service (. Freshly isolated
HFs (25/group, all derived from a single donor) were treated with
vehicle or 0.5 mM spermidine, and total RNA was isolated
according to standard protocols (TRIzol; Invitrogen-Life Tech-
nologies). The quality of total RNA was controlled via an Agilent
2100 Bioanalyzer System (Agilent Technologies, Santa Clara, CA,
USA). Linear amplification of RNA and hybridization of the
whole genome oligo microarray were performed according to the
manufacturer’s protocols (Agilent Technologies). For analysis,
after rejection of outlier features, the expressed genes showing at
least 2.0-fold differential expression were further analyzed by a
statistical test using the Cross-Gene Error Model based on
Deviation from one (recommended by Agilent Technologies).
Candidate genes were selected according to the following criteria:
equidirectional expression changes in both examined individuals,
value of P , 0.05, and changes $2-fold. All data presented in this
study is MIAME compliant and the raw data have been deposited
in a MIAME compliant database, the NCBI’s Gene Expression
Omnibus (GEO).
qPCR
Analysis of expression of specific mRNA transcripts of keratins
K15, K19 and of ODC was performed by quantitative real-time
PCR using the 59 nuclease assay (ABI PRISM 7000 Sequence
Detection System, Applied Biosystems, Foster City, CA, USA).
Total RNA was isolated from whole HFs using TRIzol and
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digested with RQ1 RNase-free DNase (Promega, Madison, WI,
USA) according to the manufacturer’s protocol. After isolation,
1 mg of RNA was reversetranscribed into cDNA using 15 U of
avian myeloblastosis virus reverse transcriptase (Promega) and
0.025 mg/ml random primers (Promega). PCR amplification was
performed using TaqMan primers and probes (assay identification
number: Hs00267035_m1 for K15, Hs01051611_gH for K19, and
Hs00189739_m1 for ODC) using the TaqMan Gene Expression
Master Mix Protocol (Applied Biosystems). A transcript of
cyclophilin A (PPIA, Hs99999904_m1) was used as a housekeeping
gene control. The amounts of the above-mentioned transcripts
were normalized to those of the control genes using the DDCt
method. During normalization, the geometric mean of the Ct
values of the four endogenous controls (provided that the SD of Ct
values of the individual housekeeping genes, obtained in triplicate
determinations, was ,0.5) was used to normalize gene expression
of the given gene of interest.
Isolation and in vitro studies with K15-GFP+ cells
Transfection of isolated hair follicles. Scalp skin was
dissected into approximately 0.5 cm2 pieces, which were washed with
PBS (37uC) to remove cell debris. These pieces were incubated
overnight in Williams E Medium (Biochrom, Cambridge, UK)
supplemented with 0.01% w/v reconstituted DispaseH (Invitrogen-
Gibco, Grand Island, NY, USA) at 4uC. After washing with PBS, the
epithelial core of single, full-length HFs were carefully plucked out
from the tissue fragments with microdissection tweezers, leaving the
HF dermal sheath retained in the skin. For further experiments, the
HFs were collected and cultured in K-SF medium (Invitrogen-Gibco,
Carlsbad, CA, USA) or directly transfected with a human K15
promoter-driven GFP expression construct as described [37,38].
Direct immunofluorescence microscopic analysis was used to
evaluate the expression of GFP. As negative controls, DispaseH
treated, microdissected and only LipofectamineH (Invitrogen,
Karlsruhe, Germany) treated HFs were used. For positive controls
an ubiquitously GFP expressing construct was used to transfect the
HFs. All samples were viewed and photographed using a Keyence BZ
8000 fluorescence microscope. Densitometric measurements of GFP
intensity and statistical analysis were performed as previously
described [37,38].
Isolation, selection and culture of human K15-GFP+
cells. To isolate and culture K15-GFP+ cells positively
transfected HFs were processed as described previously [37,38].
To test the influence of spermidine, it was added to the K15-GFP+
cell culture with an adjusted concentration of 0.1, 0.5, and 1 mM.
Semi- and quantitative RT-PCR for expression analysis of
K15. Total RNA was isolated from an equivalent number of
control and K15-GFP+ cells (,10.000 cells/dish) of vehicle and
spermidine treated K15-GFP+ cells by using RNeasy Mini Kit
(Qiagen, Germany) according to the manufacturer’s protocol.
Total RNA (100 ng) was reversed transcribed in 20 ml using the
Perkin-Elmer RNA PCR kit (Branchburg, NJ). For quantitative
analysis of K15 and the housekeeping gene ribosomal protein S26
(rS26), parts of the cDNA products (2 ml) were subjected to
PCR analysis. K15 cDNA was amplified with primers K15-f
(59-GGAGGTGGAAGCCGAAGTAT-39) and K15-r (59-GAGA-
GGAGACCACCATCGCC-39). For comparative analysis rS26
was amplified with primers rS26-f (59-CCGTGCCTCCAAG-
ATGACAAAG-39) and rS26-r (59-ACTCAGCTCCTTACAT-
GGGCTT-39). For quantitative qPCR expression analysis of
K15, GFP and rS26 100 ng RNA was reverse transcribed in a total
of 20 ml using the LightCyclerH RNA-Master-SYBR-Green-I-kit
and the LightCyclerH 2.0 instrument (Roche). For qPCR analysis
of K15 and rS26 cDNA was amplified with primers as described
above. Vehicle treated K15-GFP+ cells were used as controls. For
quantification analysis the LightCyclerH Software 4.05 (Roche)
was used. The results represent three independent experiments
and data expressed as means6SEM.
Colony forming efficiency. For colony forming efficiency
assays under the influence of spermidine K15-GFP+ cells were
seeded onto a 35 mm culture dish coated with collagen IV and
fibronectin (100 cells/well). K15-GFP+ cells were cultured as
previously described [37,38]. The analysis of the clonal potential
was carried out as previously described [37,38]. Vehicle treated
K15-GFP+ cells were used as controls. The results represent 3
independent experiments and data expressed as means6SEM.
Cell proliferation. For the detection of proliferating K15-
GFP+ cells after 1 day, 3 days, and 6 days under spermidine
treatment, K15-, Ki-67-, and DAPI labeling was performed as
described previously [37,38]. Vehicle treated K15-GFP+ cells
were used as control for the Ki-67 reaction. The results were
expressed as mean percentage of treated cells compared to the
vehicle control sample of 3 independent experiments and data
expressed as means6SEM.
Cell proliferation assays
Primary human keratinocytes were isolated as described by
Rheinwald and Green [68] from fronto-temporal scalp skin
specimens, obtained with written informed consent during routine
face-lift surgery (Caucasian females over 45 y). The East London
and City Health Authority Research Ethics Committee approved
the use of redundant human skin for this study. After isolation,
keratinocytes were cultured in keratinocyte serum free medium (K-
SFM) (Invitrogen, Paisley, UK) at 37uC in a humidified atmosphere
of 5%CO2/95% air. Spermidine (Sigma-Aldrich, Poole, UK) was
added to the culture medium at 0.1, 0.5, and 1.0 mM concentrations
for 48 h. After 48 h cell proliferation was assayed using fluorometric
reagent Cell Quanti Blue (BioAssay Systems, CA USA). The
CellQuanti Blue reagent was diluted 1 in 10 in K-SFM and added
to the cells for 1 h. Fluorescence was measured using a Bio Tek
Synergy HT plate reader with KC4 software (Bio Tek, VT, USA)
with a 530 nm excitation filter and a 590 nm emission filter.
Cell cycle analysis by propidium iodide flow cytometry
After 24 h +/2 spermidine primary human keratinocytes were
trypsinised, washed with PBS and fixed in 70% ethanol at 4uC
overnight. Cells were resuspended in 50 mg/ml propidium
iodide(PI) (Sigma-Aldrich), 100 mg RNaseA (Sigma-Aldrich),
3.8 mM sodium citrate in PBS and incubated at 4uC over night.
For each sample 100000 cells were analysed using a LSRII flow
cytometer with FACSDiva software (v 5.1.03) (both BD Biosci-
ences, CA USA). The detector was set to linear, PI excitation at
488 nm and emission collected in the 610–620 channel, cells were
gated on width and area to exclude doublets.
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